logo
5 takeaways from health insurers' new pledge to improve prior authorization

5 takeaways from health insurers' new pledge to improve prior authorization

Yahoo24-06-2025
Nearly seven months after the fatal shooting of an insurance CEO in New York drew widespread attention to health insurers' practice of denying or delaying doctor-ordered care, the largest U.S. insurers agreed Monday to streamline their often cumbersome preapproval system.
Dozens of insurance companies, including Cigna, Aetna, Humana, and UnitedHealthcare, agreed to several measures, which include making fewer medical procedures subject to prior authorization and speeding up the review process. Insurers also pledged to use clear language when communicating with patients and promised that medical professionals would review coverage denials.
While Trump administration officials applauded the insurance industry for its willingness to change, they acknowledged limitations of the agreement.
'The pledge is not a mandate,' Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, said during a news conference. 'This is an opportunity for the industry to show itself.'
Oz said he wants insurers to eliminate preapprovals for knee arthroscopy, a common, minimally invasive procedure to diagnose and treat knee problems. Chris Klomp, director of the Center for Medicare at CMS, recommended prior authorization be eliminated for vaginal deliveries, colonoscopies, and cataract surgeries, among other procedures. Health insurers said the changes would benefit most Americans, including those with commercial or private coverage, Medicare Advantage, and Medicaid managed care.
The insurers have also agreed that patients who switch insurance plans may continue receiving treatment or other health care services for 90 days without facing immediate prior authorization requirements imposed by their new insurer.
But health policy analysts say prior authorization — a system that forces some people to delay care or abandon treatment — may continue to pose serious health consequences for affected patients. That said, many people may not notice a difference, even if insurers follow through on their new commitments.
'So much of the prior authorization process is behind the black box,' said Kaye Pestaina, director of the Program on Patient and Consumer Protections at KFF, a health information nonprofit that includes KFF Health News.
Often, she said, patients aren't even aware that they're subject to prior authorization requirements until they face a denial.
'I'm not sure how this changes that,' Pestaina said.
The pledge from insurers follows the killing of UnitedHealthcare CEO Brian Thompson, who was shot in midtown Manhattan in early December on the way to an investor meeting, forcing the issue of prior authorization to the forefront.
Oz acknowledged 'violence in the streets' prompted Monday's announcement. Klomp told KFF Health News that insurers were reacting to the shooting because the problem has 'reached a fever pitch.' Health insurance CEOs now move with security details wherever they go, Klomp said.
'There's no question that health insurers have a reputation problem,' said Robert Hartwig, an insurance expert and a clinical associate professor at the University of South Carolina.
The pledge shows that insurers are hoping to stave off 'more draconian' legislation or regulation in the future, Hartwig said.
But government interventions to improve prior authorization will be used 'if we're forced to use them,' Oz said during the news conference.
'The administration has made it clear we're not going to tolerate it anymore,' he said. 'So either you fix it or we're going to fix it.'
Here are the key takeaways for consumers:
Health insurers will still be allowed to deny doctor-recommended care, which is arguably the biggest criticism that patients and providers level against insurance companies. And it isn't clear how the new commitments will protect the sickest patients, such as those diagnosed with cancer, who need the most expensive treatment.
Most states have already passed at least one law imposing requirements on insurers, often intended to reduce the time patients spend waiting for answers from their insurance company and to require transparency from insurers about which prescriptions and procedures require preapproval. Some states have also enacted 'gold card' programs for doctors that allow physicians with a robust record of prior authorization approvals to bypass the requirements.
Nationally, rules proposed by the first Trump administration and finalized by the Biden administration are already set to take effect next year. They will require insurers to respond to requests within seven days or 72 hours, depending on their urgency, and to process prior authorization requests electronically, instead of by phone or fax, among other changes. Those rules apply only to certain categories of insurance, including Medicare Advantage and Medicaid.
Beyond that, some insurance companies committed to improvement long before Monday's announcement. Earlier this year, UnitedHealthcare pledged to reduce prior authorization volume by 10%. Cigna announced its own set of improvements in February.
For example, the Affordable Care Act already requires insurers to communicate with patients in plain language about health plan benefits and coverage.
But denial letters remain confusing because companies tend to use jargon. For instance, AHIP, the health insurance industry trade group, used the term 'non-approved requests' in Monday's announcement.
Insurers also pledged that medical professionals would continue to review prior authorization denials. AHIP claims this is 'a standard already in place.' But recent lawsuits allege otherwise, accusing companies of denying claims in a matter of seconds.
Health insurers issue millions of denials every year, though most prior authorization requests are quickly, sometimes even instantly, approved.
The use of AI in making prior authorization decisions isn't new — and it will probably continue to ramp up, with insurers pledging Monday to issue 80% of prior authorization decisions 'in real-time' by 2027.
'Artificial intelligence should help this tremendously,' Rep. Gregory Murphy, R-N.C., a physician, said during the news conference.
'But remember, artificial intelligence is only as good as what you put into it,' he added.
Results from a survey published by the American Medical Association in February indicated 61% of physicians are concerned that the use of AI by insurance companies is already increasing denials.
Oz said CMS will post a full list of participating insurers this summer, while other details will become public by January.
He said insurers have agreed to post data about their use of prior authorization on a public dashboard, but it isn't clear when that platform will be unveiled. The same holds true for 'performance targets' that Oz spoke of during the news conference. He did not name specific targets, indicate how they will be made public, or specify how the government would enforce them.
While the AMA, which represents doctors, applauded the announcement, 'patients and physicians will need specifics demonstrating that the latest insurer pledge will yield substantive actions,' the association's president, Dr. Bobby Mukkamala, said in a statement. He noted that health insurers made 'past promises' to improve prior authorization in 2018.
Meanwhile, it also remains unclear what services insurers will ultimately agree to release from prior authorization requirements.
Patient advocates are in the process of identifying 'low-value codes,' Oz said, that should not require preapproval, but it is unknown when those codes will be made public or when insurers will agree to release them from prior authorization rules.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.
This article was originally published on NBCNews.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Medicaid Cuts Threaten to Stall a Breakthrough in Addiction Care
Medicaid Cuts Threaten to Stall a Breakthrough in Addiction Care

Newsweek

time42 minutes ago

  • Newsweek

Medicaid Cuts Threaten to Stall a Breakthrough in Addiction Care

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The first wave of the opioid epidemic began 26 years ago, and it continues to be a major issue for the health care system today. However, there is one treatment model that shows promise—but it could see progress stunted by future Medicaid cuts. In 2022, 81,806 opioid-involved overdose deaths occurred in the United States, more than any year prior. However, in 2024, overdose deaths relating to synthetic opioids dropped by almost 37 percent from 2023. A form of treatment that has proved and could continue to prove beneficial for treating opioid use disorder (OUD) is the collaborative care model (CoCM). In the SUMMIT randomized clinical trial, published in 2017, 32.8 percent of patients in a CoCM displayed abstinence from opioids or alcohol, as compared to 22.3 percent in standard care. Collaborative care models are revolutionizing treatment for opioid use disorder, combining the expertise of a primary care doctor, behavioral health clinician and consulting specialist, like a psychiatrist or addiction medicine specialist. Collaborative care models are revolutionizing treatment for opioid use disorder, combining the expertise of a primary care doctor, behavioral health clinician and consulting specialist, like a psychiatrist or addiction medicine specialist. Photo-illustration by Newsweek/Canva How do collaborative care models work? The CoCM is depicted as a triangle and involves a behavioral health clinician, a consulting specialist (like a psychiatrist or addiction medicine specialist) and a primary care provider, collaborating to provide behavioral health services to a patient. This treatment model stems from research conducted at the University of Washington at its Advancing Integrated Mental Health Solutions (AIMS) Center to understand whether it was possible to leverage the power of the relationship between a primary care physician and their patient while also increasing access to mental health services. Dr. Rachel E. Kishton, a physician at Penn Medicine, headquartered in Philadelphia, was recently named medical director of the Penn Integrated Care (PIC) program, where she oversees Penn's integrated and collaborative care programs. "By including everything within the primary care setting and centering that relationship between the primary care physician and the patient, you get over the hump of the fear and stigma related to it but also start from a place of trust," Kishton told Newsweek. Collaborative care models have been used to treat individuals with disorders like OUD and alcohol use disorder but are also used to treat mental health disorders. Within this lies the biggest challenge in treating patients for OUD using a CoCM. More often than not, OUD is accompanied by comorbid mental health disorders. According to Kishton, the need for a shift to more immediate and definitive treatment for mental health disorders is overlooked, compared to other disciplines in medicine. Kishton provided the metaphor of a patient having a heart attack. In that scenario, the patient should be rushed to the catheterization lab, not kept in an outpatient office and given aspirin. The distinction isn't always clear when a patient is having a mental health crisis. Physicians need better guidelines to respond to behavioral health patients with the proper level of urgency, the same way they would for a patient experiencing physical symptoms. "More research is definitely needed to understand when you send someone to the cath lab," she said, continuing the metaphor. "We need to ensure this research is continued to understand what the next steps are." Dr. Tyler Winkelman, a primary care physician at Hennepin Healthcare in Minneapolis, explained that often patients with depression or anxiety come in with the understanding that they have the disorder, whereas OUD patients often have yet to recognize what they're dealing with. "We've had a lot of success in referring patients with anxiety, depression and alcohol use disorders to the model," Winkelman said. "It has been trickier to figure out how to adapt the model for people with opioid use disorder." As a result of this, Hennepin recently started shifting its CoCM strategy. It previously treated OUD similarly to mental health disorders and is now using the model to prioritize care coordination and access, since that's what the patient population needs most. The collaborative care model is a highly evidence-based and adaptable form of treatment. The behavioral health clinician in the model will typically utilize evidence-based therapy modalities, including cognitive behavioral therapy and behavioral activation. The typical progression for these programs is six to eight sessions with a therapist over three to four months. However, despite the model appearing somewhat formulaic, Kishton emphasized that collaborative care programs vary across institutions. "If you've seen one collaborative care program, you've seen one collaborative care program," Kishton said. "They can be very different, depending on what the goals are, where the funding's coming from and what the core patient group is that you're working with." How do collaborative care models help build patient trust? In addition to Penn Medicine, other institutions around the country are working to create collaborative care programs to serve this patient population. Dr. Gavin B. Bart, who has been a physician of internal and addiction medicine at Hennepin Healthcare for 20 years now, believes the collaborative care model is instrumental in helping people with substance-abuse disorders. "People with substance use disorders are complicated because they've been so marginalized by the health care system," Bart said. "Having care coordination within a single site helps prevent the fragmentation of care that is sort of the standard right now." The CoCM addresses this fragmentation of care by providing patients with direct and immediate access to care within one facility, preventing them from having to find and build trust with a new provider. "The initial part of treating addiction requires much more upfront management to make sure the patient's needs are being mapped, their withdrawal is being managed and other medical issues are managed," said Bart. "And it should be done in a quick manner, otherwise the patients walk away and don't come back." Nurse Practitioner Brenda Bauch works within Hennepin's addiction clinic and shed some light on the vulnerability patients often come into the clinic with. "We see patients who often have a distrust of doing something new," Bauch said. "We have access to effective FDA-approved medications for OUD. That's wonderful and can be life-changing. But initially, it's about saying, 'You're welcome here in wherever you're at in your state of transformative change.'" Could Medicaid cuts limit access to collaborative care? Hennepin Healthcare provides services through grants provided by the Substance Abuse and Mental Health Services Administration (SAMHSA). However, Minnesota's state Medicaid agency is yet to adopt the billing codes that cover the cost of a collaborative care program. Bart and Winkelman from Hennepin Healthcare expressed concern regarding pending Medicare and Medicaid cuts. "As a public safety net hospital, we're certainly concerned about the potential cuts," Bart said. "The best we can do to preserve our finances is not squander the knowledge we've gathered through research and public health information. There's data that tells us for every dollar invested in treatment, the amount of savings that occur elsewhere in society in terms of reduced rates of incarceration, increased employment rates and more. We need to not lose touch with that as we create our plans, moving forward, to make America healthy." Despite this possible obstacle, Hennepin Healthcare has been largely successful in helping OUD patients transform their lives. Aside from sharing concerns regarding the financial sustainability of the collaborative care program at Hennepin, Winkelman, too, is "extremely optimistic" about the model's future in treating OUD and other disorders. "I've had so many patients in the last two years benefit dramatically from these services, and we've really been able to help patients get back on their feet," he said. "It has improved the quality of health care that we've provided. And I really see it as the standard of care moving forward in primary care." What's on the horizon for collaborative care models? Currently, research is shifting to examine not only how the collaborative care model can address substance abuse symptoms but also the co-occurring mental health conditions. Penn Medicine's Whole Health Study focused on this with a randomized controlled trial designed to assess collaborative care models and their effectiveness in treating patients for OUD and the comorbid mental disorders that accompany it. The study utilized three conditions. In the first, primary care doctors were prescribing buprenorphine and referring patients out for mental health care. Currently, buprenorphine, a Schedule 3 controlled substance, is one of the medications most commonly used to treat OUD and help patients reduce or quit their opioid usage. In the second condition, a collaborative care model was implemented with a licensed clinical social worker and a psychiatrist who were providing mental health treatment within the primary care practice. The final condition added a peer or certified recovery specialist to increase treatment engagement and retention. The study's principal investigator, David Mandell, professor of psychiatry and director of the Penn Center for Mental Health, shared details regarding the initial results the center recently shared with the College on Problems of Drug Dependence (CPDD) organization in New Orleans. "In all three conditions, there's a substantial reduction in opioid use, and [use] stays low for the six months they're in [the CoCM]," said Mandell. "But our collaborative care condition also results in substantial reduction in psychiatric symptoms and even remission from psychiatric disorder, relative to the usual care condition." According to the study's protocol published in 2021, poor treatment retention is relatively common in CoCMs treating OUD. Mandell described a few reasons why this occurs: the location of care sites, which can make it difficult to live one's life during treatment; punitive measures and caregivers' refusal to see patients after relapses; and problems that accompany opioid use, like food insecurity and housing instability. The center recruited participants from among primary care doctors' existing patients; these patients had either initiated treatment or had been in treatment for some time but were still experiencing psychiatric distress. Hence, convincing patients to begin treatment wasn't necessarily part of conducting the study. "One of the really exciting things we see is, across the conditions tested, 80 percent of people stayed in treatment," Mandell said. "This suggests they liked their doctors, thought the treatment was effective and thought people were meeting them where they were." Mandell believes one of the main reasons for this is the harm reduction approach used by Penn primary care doctors, in which they're more responsive to patients' needs and don't use the punitive approach often taken to OUD patients. When asked about the most rewarding part of the trial, Mandell mentioned seeing how much the primary care doctors loved the model, because they've been eager to secure a high level of support for their patients for a long time. Mandell also enjoyed reading patient testimonials, talking about how much they loved their therapists and benefited from their treatment. "The emails we get, where they say, 'You've turned my life around. Things are so great,' relative to what they were. 'I don't know what I would've done without this social worker.' That's very rewarding," said Mandell. To ensure success, Mandell had a multidisciplinary team working alongside him, and working with the members has been one of his favorite parts of leading the trial because of their determination to help this patient population. "This patient population has a lot of stigma around it, and many people are not interested in helping these folks," he said. "They believe, 'You could stop if you wanted,' and 'You get what you deserve.' But these are people really committed to helping OUD patients and figuring out the best way to support them. And that has just absolutely restored my faith in humanity."

Looming Medicaid cuts prompt caregiver concern on Long Island. Why they say "we are nervous"
Looming Medicaid cuts prompt caregiver concern on Long Island. Why they say "we are nervous"

CBS News

timean hour ago

  • CBS News

Looming Medicaid cuts prompt caregiver concern on Long Island. Why they say "we are nervous"

New York faces significant impacts due to federal Medicaid cuts. Supporters of the cuts say the changes will reduce fraud and abuse, but others worry about impacts to the vulnerable. Former college athlete and administrative assistant Lisa Pope is among the Medicaid dependent Long Islanders that rely on nonprofit human services organizations that offer addiction and mental health treatment. She's now on a positive path forward, thanks in part to the Thrive/Family and Children's Association. "I'm 59 years old. I've been in recovery now for 20 months," Pope said. "Medicaid is important for my life right now, it's been a life save. It's given me the support that I need. The counselors are there." "But as the changes started happening in Washington, D.C., we're nervous," said Dr. Jeffrey Reynolds of the Family and Children's Association. Reynolds said he was about to expand the Family and Children's Association and open a $7 million mental health, substance abuse and primary care facility in Westbury. But after Congress passed what the Trump administration dubbed the Big Beautiful Bill Act in July, cuts to Medicaid are looming. "So we canceled the project, a really painful decision," Reynolds said. "We are going to see devastating impacts on our community because of the cuts in this big, ugly bill," Rep. Laura Gillen said. Gillen and Reynolds were invited to Thrive Center in Westbury to hear first hand from counselors and clients. The Medicaid cuts are due to take effect in 2026. The Trump administration said the cuts are aimed at eliminating waste, fraud, and abuse within the Medicaid program, and will curb unsustainable spending growth. Thrive peer counselor and former addict Ryan Kiser is worried about the impact. "It's a frightening thing. To ask for help, it can be such a fleeting moment. Any barriers that come in between someone and any potential recovery supports could potentially cost a life," Kiser said.

Fewer Americans than ever confident in food safety regulations: Gallup
Fewer Americans than ever confident in food safety regulations: Gallup

The Hill

time2 hours ago

  • The Hill

Fewer Americans than ever confident in food safety regulations: Gallup

Confidence in the government's ability to ensure food safety in the U.S. has hit a new low — a drop driven largely by distrust among Democrats, according to a poll released Monday. Gallup's latest survey of consumer habits found that 53 percent of Americans said they have at least a 'fair amount' of faith in federal regulators maintaining a safe food supply. Confidence had hovered around 70 percent from 2007 to 2019, based on Gallup's previous findings, but it fell below 60 percent for the first time last year and continued to drop. The latest poll found that confidence among Republicans in the government's ability to maintain food safety held steady at 41 percent from last year to this year after President Trump's return to the White House, but confidence fell off among Democrats. About 74 percent of Democrats expressed confidence in federal food safety oversight in 2024, compared to 48 percent this year. Health Secretary Robert F. Kennedy Jr. has heavily emphasized food as part of his overhaul of federal health care initiatives, but sweeping budget cuts across the federal government and has raised additional concerns at the FDA. Officials have maintained that none of the cuts impacted the number of inspectors or other food regulators. The Associated Press reported in April that the FDA had been struggling for years to ramp up inspections after the COVID-19 pandemic and that outside contractors were being hired to fill some inspector roles. The FDA, which has issued about 100 safety alerts and food recalls this year based on the agency's active database, penned a letter to food industry leaders last month urging better communication about product safety concerns. 'At the FDA, we believe that radical transparency in food safety and nutrition actions is key to reducing foodborne illness and chronic disease, setting a strong foundation for lifelong health,' FDA Commissioner Marty Makary wrote in the memo, specifically highlighting concerns about chemical contaminants in foods for infants and toddlers. The Gallup poll surveyed 1,002 adults July 7-21 across all U.S. states and the District of Columbia. It has a margin of error of 4 percentage points.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store